System, including method and apparatus for percutaneous endovascular treatment of functional mitral valve insufficiency

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060281968A1
SERIAL NO

11447648

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Among the four heart valves, the mitral is the most frequently affected by disease resulting in defective valve opening (stenosis) or incomplete closure (insufficiency). Most often this is due to distortion of the valve apparatus secondary to rheumatic or degenerative disease. These lesions, called 'organic' require open heart surgery. In patients with coronary disease or with dilated cardiomyopathy the mitral valve can be insufficient although structurally normal. These valves are 'functionally' insufficient. Because of the poor condition of these patients where open heart surgery carries a significant operative risk, less invasive percutaneous alternatives are being explored today. The present novel invention represents a radical departure from other procedures because it repositions the posterior papillary muscle utilizing a device located in the interventricular veins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTERNATIONAL HEART INSTITUTE OF MONTANA FOUNDATION THE554 WEST BROADWAY MISSOULA MT 59802

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
de, Ubago Yon Patrik Martinez Missoula, MT 1 21
Duran, Carlos MG Missoula, MT 1 21
Martinez, de Ubago Jose Luis Missoula, MT 1 21
Sanz, Mark L Missoula, MT 1 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation